Comment

UCL Technology Fund: an unparalleled approach to commercialisation
Editor Thierry Heles sits down with David Grimm (pictured), manager of the UCL Technology Fund, to find out what makes the fund unique among its UK and international peers.
Editorial: For the good of investors
As MedWhat scores an initial win in its courtroom battle with Stanford, Paige.ai finds itself in the middle of allegations that its licensing deal with Sloan Kettering was improper.
Stacking the odds in universities’ favour
The GUV September issue editorial by Thierry Heles.
Why we are in trouble if we don’t change education
“Developers will be at the centre of solving the world’s most pressing challenges.”
As revenue pressures increase, tech transfer offices must evolve
Tech transfer offices are under increasing pressure to generate revenue, but an innovative tech transfer strategy can help them deliver.
Editorial: The current and future state of UVFs
Editor-in-chief James Mawson takes a look at assumed problems around university IP and considers the opportunities of university venture funds ahead of a report by Hermann Hauser.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.

News Continued

How to lose the innovation arms race
A report released last week by the Center for Advancing Innovation and PatSnap shows the US and the EU are falling behind on the number of patents filed.
The shape of things to come
July - August issue editorial by Thierry Heles, editor
Opportunities and challenges abound at PraxisAuril conference
PraxisAuril's spring conference continues to go from strength to strength, with one in three delegates a first-time attendant.
Bridging the gap between man and machine
The quest for human-machine interfaces is increasingly driving CVC investments.
The road to gender equality remains long
June issue editorial by GUV editor Thierry Heles.

Editor's Picks

UCL Technology Fund: an unparalleled approach to commercialisation
Editor Thierry Heles sits down with David Grimm (pictured), manager of the UCL Technology Fund, to find out what makes the fund unique among its UK and international peers.
Editorial: For the good of investors
As MedWhat scores an initial win in its courtroom battle with Stanford, Paige.ai finds itself in the middle of allegations that its licensing deal with Sloan Kettering was improper.
Editorial: The current and future state of UVFs
Editor-in-chief James Mawson takes a look at assumed problems around university IP and considers the opportunities of university venture funds ahead of a report by Hermann Hauser.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
test reg

Login

Not yet subscribed?

See your subscription offers here